Investigation of Homocysteine-Pathway-Related Variants in Essential Hypertension

Hyperhomocysteinemia (hHcy) has been associated with an increased risk of cardiovascular disease and stroke. Essential hypertension (EH), a polygenic condition, has also been associated with increased risk of cardiovascular related disorders. To investigate the role of the homocysteine (Hcy) metabol...

Full description

Saved in:
Bibliographic Details
Main Authors: Javed Y. Fowdar, Marta V. Lason, Attila L. Szvetko, Rodney A. Lea, Lyn R. Griffiths
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:International Journal of Hypertension
Online Access:http://dx.doi.org/10.1155/2012/190923
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556256925057024
author Javed Y. Fowdar
Marta V. Lason
Attila L. Szvetko
Rodney A. Lea
Lyn R. Griffiths
author_facet Javed Y. Fowdar
Marta V. Lason
Attila L. Szvetko
Rodney A. Lea
Lyn R. Griffiths
author_sort Javed Y. Fowdar
collection DOAJ
description Hyperhomocysteinemia (hHcy) has been associated with an increased risk of cardiovascular disease and stroke. Essential hypertension (EH), a polygenic condition, has also been associated with increased risk of cardiovascular related disorders. To investigate the role of the homocysteine (Hcy) metabolism pathway in hypertension we conducted a case-control association study of Hcy pathway gene variants in a cohort of Caucasian hypertensives and age- and sex-matched normotensives. We genotyped two polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR C677T and MTHFR A1298C), one polymorphism in the methionine synthase reductase gene (MTRR A66G), and one polymorphism in the methylenetetrahydrofolate dehydrogenase 1 gene (MTHFD1 G1958A) and assessed their association with hypertension using chi-square analysis. We also performed a multifactor dimensionality reduction (MDR) analysis to investigate any potential epistatic interactions among the four polymorphisms and EH. None of the four polymorphisms was significantly associated with EH and although we found a moderate synergistic interaction between MTHFR A1298C and MTRR A66G, the association of the interaction model with EH was not statistically significant (P=0.2367). Our findings therefore suggest no individual or interactive association between four prominent Hcy pathway markers and EH.
format Article
id doaj-art-e18a8f222a5f43af9e22f880abdb3cb8
institution Kabale University
issn 2090-0384
2090-0392
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series International Journal of Hypertension
spelling doaj-art-e18a8f222a5f43af9e22f880abdb3cb82025-02-03T05:45:55ZengWileyInternational Journal of Hypertension2090-03842090-03922012-01-01201210.1155/2012/190923190923Investigation of Homocysteine-Pathway-Related Variants in Essential HypertensionJaved Y. Fowdar0Marta V. Lason1Attila L. Szvetko2Rodney A. Lea3Lyn R. Griffiths4Genomics Research Centre, Griffith Health Institute, Gold Coast Campus, Griffith University, Southport, QLD 4222, AustraliaGenomics Research Centre, Griffith Health Institute, Gold Coast Campus, Griffith University, Southport, QLD 4222, AustraliaGenomics Research Centre, Griffith Health Institute, Gold Coast Campus, Griffith University, Southport, QLD 4222, AustraliaGenomics Research Centre, Griffith Health Institute, Gold Coast Campus, Griffith University, Southport, QLD 4222, AustraliaGenomics Research Centre, Griffith Health Institute, Gold Coast Campus, Griffith University, Southport, QLD 4222, AustraliaHyperhomocysteinemia (hHcy) has been associated with an increased risk of cardiovascular disease and stroke. Essential hypertension (EH), a polygenic condition, has also been associated with increased risk of cardiovascular related disorders. To investigate the role of the homocysteine (Hcy) metabolism pathway in hypertension we conducted a case-control association study of Hcy pathway gene variants in a cohort of Caucasian hypertensives and age- and sex-matched normotensives. We genotyped two polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR C677T and MTHFR A1298C), one polymorphism in the methionine synthase reductase gene (MTRR A66G), and one polymorphism in the methylenetetrahydrofolate dehydrogenase 1 gene (MTHFD1 G1958A) and assessed their association with hypertension using chi-square analysis. We also performed a multifactor dimensionality reduction (MDR) analysis to investigate any potential epistatic interactions among the four polymorphisms and EH. None of the four polymorphisms was significantly associated with EH and although we found a moderate synergistic interaction between MTHFR A1298C and MTRR A66G, the association of the interaction model with EH was not statistically significant (P=0.2367). Our findings therefore suggest no individual or interactive association between four prominent Hcy pathway markers and EH.http://dx.doi.org/10.1155/2012/190923
spellingShingle Javed Y. Fowdar
Marta V. Lason
Attila L. Szvetko
Rodney A. Lea
Lyn R. Griffiths
Investigation of Homocysteine-Pathway-Related Variants in Essential Hypertension
International Journal of Hypertension
title Investigation of Homocysteine-Pathway-Related Variants in Essential Hypertension
title_full Investigation of Homocysteine-Pathway-Related Variants in Essential Hypertension
title_fullStr Investigation of Homocysteine-Pathway-Related Variants in Essential Hypertension
title_full_unstemmed Investigation of Homocysteine-Pathway-Related Variants in Essential Hypertension
title_short Investigation of Homocysteine-Pathway-Related Variants in Essential Hypertension
title_sort investigation of homocysteine pathway related variants in essential hypertension
url http://dx.doi.org/10.1155/2012/190923
work_keys_str_mv AT javedyfowdar investigationofhomocysteinepathwayrelatedvariantsinessentialhypertension
AT martavlason investigationofhomocysteinepathwayrelatedvariantsinessentialhypertension
AT attilalszvetko investigationofhomocysteinepathwayrelatedvariantsinessentialhypertension
AT rodneyalea investigationofhomocysteinepathwayrelatedvariantsinessentialhypertension
AT lynrgriffiths investigationofhomocysteinepathwayrelatedvariantsinessentialhypertension